Therefore, we investigated the expression and epigenetic regulation of SEC23A in STAD, its possible pathogenic mechanism, and its correlation with prognostic parameters by combining bioinformatics with expression analyses in fresh tissue samples. This evidence concerns the gene SEC23A and gastric adenocarcinoma.